Medtronic Endovascular

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Neurology · Renal & urogenital · Women's health

Medtronic Endovascular is a clinical trial sponsor. It has 2 active clinical trials with 149 planned participants, across 7 therapeutic areas. Since 2021 it has completed 11 trials and stopped 5 early.

Trial track record · since 2021

2Active trials149 planned participants
11Completed9 with results posted
5Stopped early31% of finished trials

Pipeline · 2 active trials

StageTrialStatus

Questions about Medtronic Endovascular

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Medtronic Endovascular.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.